3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Plasma cell
1
Other hematologic neoplasm
1
Myeloid
1
Head & Neck
1
Gynecologic
1
Gastrointestinal
1
Endocrine
1
Dermatologic
1
CNS
1
Conditions
Colorectal Neoplasms
8
Pancreatic Neoplasms
5
Carcinoma, Non-Small-Cell Lung
5
Ovarian Neoplasms
4
Neoplasms
4
Melanoma
3
Gastrointestinal Neoplasms
3
Cholangiocarcinoma
3
Breast Neoplasms
3
Urinary Bladder Neoplasms
2
Prostatic Neoplasms
2
Neoplasms by Site
2
Multiple Myeloma
2
Hematologic Neoplasms
2
Gallbladder Neoplasms
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Thyroid Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Thyroid Cancer, Papillary
1
Thrombocytosis
1
Thoracic Neoplasms
1
Skin Neoplasms
1
Sarcoma
1
Respiratory Tract Neoplasms
1
Respiratory Tract Diseases
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Adenocarcinoma
1
Noonan Syndrome
1
Interventions
Magnetic Resonance Spectroscopy
11
Specimen Handling
8
X-Rays
7
Phantoms, Imaging
6
Nuclear Medicine Department, Hospital
6
Biopsy
6
olaparib
4
ulixertinib
3
trametinib
3
palbociclib
3
larotrectinib
3
ivosidenib
3
erdafitinib
3
dabrafenib
3
Vemurafenib
3
tipifarnib
2
tazemetostat
2
selpercatinib
2
ensartinib
2
durvalumab
2
Nivolumab
2
LY3023414
2
Gemcitabine
2
Doxorubicin
2
Docetaxel
2
Cisplatin
2
trastuzumab deruxtecan
1
trastuzumab biosimilar HLX02
1
sonidegib
1
sargramostim
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Glioma
×
cobimetinib
×
Gastrointestinal
×
Clear all
NCT05768178
2025-11-24
DETERMINE
Cancer Research UK
Phase 2/3
Recruiting
30 enrolled